Video Experimental Relacionado
Updated: May 30, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Una vancomicina rediseñada diseñada para la doble unión D-Ala-D-ala y D-Ala-D-Lac exhibe una potente actividad
Jian Xie1, Joshua G Pierce, Robert C James
1Department of Chemistry, The Skaggs Institute for Chemical Biology, La Jolla, California 92037, United States.
Journal of the American Chemical Society
|August 10, 2011
Resumen
Un nuevo derivado de la vancomicina, [Ψ[C[(NH) NH]Tpg(4)]aglicona de vancomicina, restaura la actividad antimicrobiana contra las bacterias resistentes a la vancomicina al unirse a las dianas d-Ala-d-Ala y d-Ala-d-Lac.
Área de la Ciencia:
- Microbiología Microbiología.
- Química Medicinal La Química Medicinal es el campo de la Química Medicinal.
- Descubrimiento de Drogas Descubrimiento de Drogas
Sus antecedentes:
- La resistencia a la vancomicina en las bacterias es una amenaza significativa para la salud mundial.
- Las bacterias resistentes alteran sus precursores de la pared celular, reduciendo la eficacia de la vancomicina.
- La modificación d-Ala-d-Lac en el peptidoglicano es un mecanismo clave de la resistencia a la vancomicina.
Objetivo del estudio:
- Diseñar y sintetizar un derivado de la vancomicina con capacidad de doble unión.
- Para restaurar la actividad antimicrobiana contra las cepas bacterianas resistentes a la vancomicina.
- Desarrollar una nueva estrategia terapéutica para combatir las infecciones resistentes.
Principales métodos:
- Síntesis química de [Ψ[C[(NH) NH]Tpg(4)]vancomicina y aglicona.
- Ensayos de afinidad de unión con los ligandos d-Ala-d-Ala y d-Ala-d-Lac.
- Prueba de actividad antimicrobiana contra los enterococos resistentes a la vancomicina (ERV).
Principales resultados:
- El nuevo derivado exhibió una fuerte unión tanto a d-Ala-d-Ala como a d-Ala-d-Lac.
- La afinidad de unión con d-Ala-d-Lac se mejoró significativamente en comparación con la vancomicina aglicona.
- Se demostró una potente actividad antimicrobiana contra VanA VRE con una concentración inhibidora mínima (MIC) de 0,31 microg / ml.
Conclusiones:
- Una modificación de un solo átomo en la vancomicina puede superar los mecanismos de resistencia.
- El derivado diseñado ofrece un enfoque prometedor para el tratamiento de infecciones bacterianas resistentes a la vancomicina.
- Esta estrategia proporciona una base racional para el desarrollo de antibióticos de próxima generación.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
00:57Antibiotic Selection
Overview
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...